Swiss National Bank
LJPC

Swiss National Bank’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Swiss National Bank’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-34,800
Closed -$224K – 2618
2019
Q1 		$224K Hold
34,800
– – ﹤0.01% 2490
2018
Q4 		$328K Buy
34,800
+1,700
+5% +$25.6K ﹤0.01% 2456
2018
Q3 		$666K Hold
33,100
– – ﹤0.01% 2336
2018
Q2 		$966K Hold
33,100
– – ﹤0.01% 2178
2018
Q1 		$986K Buy
33,100
+3,700
+13% +$119K ﹤0.01% 2082
2017
Q4 		$946K Hold
29,400
– – ﹤0.01% 2124
2017
Q3 		$1.02M Hold
29,400
– – ﹤0.01% 2053
2017
Q2 		$875K Hold
29,400
– – ﹤0.01% 2139
2017
Q1 		$878K Buy
29,400
+5,000
+20% +$128K ﹤0.01% 2108
2016
Q4 		$428K Hold
24,400
– – ﹤0.01% 2446
2016
Q3 		$580K Hold
24,400
– – ﹤0.01% 2282
2016
Q2 		$390K Hold
24,400
– – ﹤0.01% 2456
2016
Q1 		$493K Buy
24,400
+4,400
+22% +$78.5K ﹤0.01% 2313
2015
Q4 		$540K Buy
+20,000
New +$545K ﹤0.01% 2216

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swiss National Bank's LJPC Position: Q2 2019 in Review

Swiss National Bank sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 34,800 shares — an estimated $224K sold.

Swiss National Bank first reported a position in LJPC in Q4 2015 and held it in 14 quarters. The position peaked at $1.02M in Q3 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Swiss National Bank reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Swiss National Bank sold 34,800 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $224K.
  • Swiss National Bank first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 14 quarters.
  • Swiss National Bank's La Jolla Pharmaceutical Company position peaked at $1.02M in Q3 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.